Veterinary Medicines

U-tab 2000 mg intrauterine tablet for cattle

Authorised
  • Tetracycline hydrochloride
Download as PDF

Product identification

Medicine name:
U-tab 2000 mg intrauterine tablet for cattle
Nageboorte tablet 2000 mg intra-uteriene tablet voor runderen
Active substance:
  • Tetracycline hydrochloride
Target species:
  • Cattle
Route of administration:
  • Intrauterine use

Product details

Active substance and strength:
  • Tetracycline hydrochloride
    2000.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Intrauterine tablet
Withdrawal period by route of administration:
  • Intrauterine use
    • Cattle
      • Meat and offal
        10
        day
      • Milk
        4
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG51AA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • (ID4) 10 Intrauterine tablet: unspecified outer container with 1 Blister (Aluminium; PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride) with 10 Intrauterine tablet
  • (ID2) 5 Intrauterine tablet: unspecified outer container with 1 Blister (Aluminium; PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride) with 5 Intrauterine tablet
  • (ID3) 20 Intrauterine tablet: unspecified outer container with 1 Blister (Aluminium; PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride) with 20 Intrauterine tablet
  • (ID6) 200 Intrauterine tablet: unspecified outer container with 1 Blister (Aluminium; PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride) with 200 Intrauterine tablet
  • (ID5) 100 Intrauterine tablet: unspecified outer container with 1 Blister (Aluminium; PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride) with 100 Intrauterine tablet
  • (ID1) 50 Intrauterine tablet: unspecified outer container with 1 Blister (Aluminium; PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride) with 50 Intrauterine tablet

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Eurovet Animal Health B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Eurovet Animal Health B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 106878
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0140/001
Concerned member states:
  • Austria
  • Netherlands
  • Poland
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 7/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."